- Texture and stress measurement with the Eulerian cradle on MRD system, double-mirror setup2007 | Faculty of Mathematics and Physics
- NGS better discriminates true MRD positivity for the risk stratification of childhood ALL treated on MRD-based protocol2023 | Second Faculty of Medicine
- Standardized MRD quantification in European ALL trials: Proceedings of the Second International Symposium on MRD assessment in Kiel, Germany, 18-20 September 20082010 | Second Faculty of Medicine
- MRD response in relapsed/refractory FL after obinutuzumab plus bendamustine or bendamustine alone in the GADOLIN trial2020 | Faculty of Medicine in Hradec Králové
- MRD dynamics during maintenance for improved prognostication of 1280 patients with myeloma in the TOURMALINE-MM3 and -MM4 trials2023 | First Faculty of Medicine
- Minimal residual disease (MRD) analysis in the non-MRD-based ALL IC-BFM 2002 protocol for childhood ALL: is it possible to avoid MRD testing?2008 | Second Faculty of Medicine
- Patient specific real-time PCR in precision medicine - Validation of IG/TR based MRD assessment in lymphoid leukemia2023 | Second Faculty of Medicine
- Monitoring of Minimal Residual Disease (MRD) by Polymerase Chain Reaction in Patients Treated for B-Cell Nonhodgkin´s lymphomas (NHL) at the 1st Department of Internal Medicine General Faculty Hospital in PraguePublication without faculty affiliation
- Quality Control for IG /TR Marker Identification and MRD Analysis2022 | Second Faculty of Medicine
- Remarkably Fast Reduction of MRD Level In TEL/AML1-Positive ALL: RQ-PCR Study2001 | Second Faculty of Medicine, Central Library of Charles University
- Analysis of minimal residual disease (MRD) of protocol ALL IC - BFM 2002: Might the patients be stratified without MRD? +1Publication without faculty affiliation
- Prognostic impact of MRD in the bone marrow of children at first isolated extramedullary relapse of ALL.Publication without faculty affiliation
- Early MRD response as a prognostic factor in adult patients with acute lymphoblastic leukemia2016 | Second Faculty of Medicine
- Next-generation sequencing indicates false-positive MRD results and better predicts prognosis after SCT in patients with childhood ALL2017 | Second Faculty of Medicine
- Analysis of minimal residual disease by Ig/TCR gene rearrangements: guidelines for interpretation of real-time quantitative PCR data2007 | Second Faculty of Medicine
- The predictive strength of next-generation sequencing MRD detection for relapse compared with current methods in childhood ALL2015 | Second Faculty of Medicine
- Minimal residual disease of breast cancer and diagnosis MRD2006 | First Faculty of Medicine
- Comparison of Real-time Quantitative Polymerase Chain Reaction and Eight-color Flow Cytometry in Assessment of Minimal Residual Disease in Adult Acute Lymphoblastic Leukemia2018 | First Faculty of Medicine, Faculty of Medicine in Hradec Králové
- Improved survival and MRD remission with blinatumomab vs. chemotherapy in children with first high-risk relapse B-ALL2023 | Second Faculty of Medicine
- Standardized flow cytometry for highly sensitive MRD measurements in B-cell acute lymphoblastic leukemia2017 | Second Faculty of Medicine
- Minimal residual disease and outcome characteristics in infant KMT2A-germline acute lymphoblastic leukaemia treated on the Interfant-06 protocol2022 | Second Faculty of Medicine
- Minimal residual disease assessment in B-cell precursor acute lymphoblastic leukemia by semi-automated identification of normal hematopoietic cells: A EuroFlow study2024 | Second Faculty of Medicine
- Fast Reduction of TEL/AML1 Transcript Levels by RQ-PCR in 53 Paediatric TEL/AML1-Positive Patients. Comparison to Flow Cytometry MRD Detection2001 | Second Faculty of Medicine, Central Library of Charles University
- Prognostic value of MRD in CLL patients with comorbidities receiving chlorambucil plus obinutuzumab or rituximab2019 | First Faculty of Medicine
- FCM marker importance for MRD assessment in T-cell acute lymphoblastic leukemia: An AIEOP-BFM-ALL-FLOW study group report2024 | Second Faculty of Medicine
- Blinatumomab overcomes poor prognostic impact of measurable residual disease in pediatric high-risk first relapse B-cell precursor acute lymphoblastic leukemia2022 | Second Faculty of Medicine
- Quantitation of minimal residual disease in patients with chronic lymphocytic leukemia using locked nucleic acid-modified, fluorescently labeled hybridization probes and real-time PCR technology2007 | First Faculty of Medicine
- Bone Marrow Stromal Cell Regeneration Profile in Treated B-Cell Precursor Acute Lymphoblastic Leukemia Patients: Association with MRD Status and Patient Outcome2022 | Second Faculty of Medicine
- Minimal residual disease prior to stem cell transplant for childhood acute lymphoblastic leukaemia2003 | Second Faculty of Medicine
